APA (7th ed.) Citation

Singh, I., Karna, A., Prajapati, A., Solanki, U., Mukherjee, A., Uppal, S., . . . Agarwal, P. Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Singh, Ibha, Amarnath Karna, Anita Prajapati, Ujjawal Solanki, Archana Mukherjee, Sheetal Uppal, Pawan Malhotra, Manoj Kumar, and Pallavi Agarwal. Epigenetic Targeting of MECOM/KRAS Axis by JIB-04 Impairs Tumorigenesis and Cisplatin Resistance in MECOM-amplified Ovarian Cancer. Nature Publishing Group.

MLA (9th ed.) Citation

Singh, Ibha, et al. Epigenetic Targeting of MECOM/KRAS Axis by JIB-04 Impairs Tumorigenesis and Cisplatin Resistance in MECOM-amplified Ovarian Cancer. Nature Publishing Group.